Acticor Biotech gets patent for cardiovascular emergency treatment product

French company Acticor Biotech has announced the European Patent Office (EPO) has granted a new patent that provides protection for the use of Acticor’s product, glenzocimab in thrombotic diseases in Europe until 2036.

The grant in Europe complements the ones already obtained in November 2020 in the U.S. and in November 2021 in Singapore, both of which also protect glenzocimab until 2036ell. The patent is also under examination in other countries such as Japan.

To date, three patent families, including four granted patents and 33 pending patent applications, protect glenzocimab and its therapeutic use. read more


Warnings of mental health crisis among ‘Covid generation’ of students

The pandemic has had a lasting legacy on the mental health of the “Covid generation” of students, exacerbating rates of anxiety, depression and self-harm and resulting in a “significant rise” in young people struggling at university, experts have said.

UK universities have reported that more students are experiencing mental health problems in the aftermath of the pandemic, and that this is expected to continue with the cohort arriving in September, whose school experience was heavily disrupted by the pandemic.

The president of the National Union of Students, Larissa Kennedy, said she was “deeply concerned” by the student mental health crisis, which was “getting worse”, with NUS research suggesting “the majority of students are burdened by anxiety”. read more


Here’s how the Supreme Court’s Roe v. Wade decision could affect health insurance coverage

Even when Roe v. Wade was in effect and women had the legal right to an abortion no matter where they lived in the U.S., health insurance coverage of the procedure was limited.

Many states restrict what plans can cover, and a decadeslong national law bans the use of federal funds for abortions, meaning that women on Medicaid and Medicare were often not covered when it came to pregnancy terminations.

With abortion now expected to be prohibited in at least half the states after the landmark decision protecting women’s right to an abortion was overturned by the Supreme Court last week, coverage will only become rarer, experts say. read more


Weed users nearly 25% more likely to need emergency care and hospitalization

Using recreational marijuana is associated with a higher risk of emergency room care and being hospitalized for any reason, a new study has found.

“Cannabis use is not as benign and safe as some might think,” said study author Nicholas Vozoris, assistant professor and clinician investigator in the division of respirology at the department of medicine at the University of Toronto.

“Our study demonstrates that the use of this substance is associated with serious negative outcomes, specifically, ED (emergency department) visits and hospitalizations,” Vozoris said in an email. read more


Amid monkeypox outbreak, US officials plan to release 1.6M doses of Bavarian Nordic’s Jynneos vaccine

As a monkeypox outbreak quietly gains steam in the U.S. and elsewhere, American health officials are laying out a plan to stop it. One major component is vaccinations.

Tuesday, officials with the Centers for Disease Control and Prevention (CDC) revealed a plan to make available 1.6 million doses of Bavarian Nordic’s smallpox and monkeypox vaccine Jynneos by the end of the year, according to press reports. Of that total, officials will immediately make available 56,000 doses in areas of high transmission.

They’ll follow that release with another 240,000 doses in the coming weeks, then with another 750,000 doses over the rest of the summer, USA Today reports. The officials plan to release another 500,000 doses in the fall, taking the total supply to around 1.6 million doses. read more

mayo clinic

Mayo Clinic, Israeli hospital partner to help health tech startups

Rochester, Minn.-based Mayo Clinic has signed an agreement with Israel-based Sheba Medical Center that will make it easier to share healthcare technology and help early stage startups.

The two health systems will create an environment that will increase rapid product development in the U.S. and Israeli markets, according to a June 27 press release. The aim is to transform patient care using technology and to do it globally.

The partnership will initially kick off with the health tech companies in Mayo Clinic’s Platform_Accelerate program and Sheba Medical Center’s ARC Innovation Center. read more


Silicon Valley doctors decry plan to pay bonuses for seeing more patients

Local doctors are outraged over a proposal from Santa Clara County to tie some of their pay to the number of patients they see.

The physicians from three county-owned hospitals say the model will hurt patients and quality of treatment. Nine doctors from Santa Clara Valley Medical Center gathered in front of the county offices Tuesday to sound the alarm on the new pay program.

The new compensation plan, which is still short on details, is the county’s response to the physicians’ demands for higher pay to help recruit and retain doctors. Roughly 80% of physicians in Silicon Valley earn more than those working at the county hospitals, according to an analysis by the doctors’ union. This has resulted in retention issues, longer workdays, and more clerical responsibilities for doctors, union members said. read more


ARCH Defies Biotech Market Slowdown with New $3B Fund

Chicago-based ARCH Venture Partners has closed on its twelfth venture fund, ARCH Venture Fund XII, with $2.975 billion it can now invest in early-stage biotechnology companies.

This follows the company’s January 2021 announcement of ARCH Venture Fund XI, which was worth nearly $2 billion. It also follows last week’s PwC report, which noted that more than 60 biotech companies have announced layoffs so far this year, with some going out of business, and a general slowing of initial public offerings (IPOs). In 2021, 104 biotech companies launched IPOs, bringing in almost $15 billion, but to date this year there have been only 14 IPOs in the sector, raising less than $2 billion altogether. read more


U.S. FDA Classifies Recall of GE’s Ventilator Batteries as Most Serious

U.S. health regulators on Tuesday classified the recall of some backup batteries of GE Healthcare’s ventilators, which the company had initiated in mid-April, as the most serious type, saying that their use could lead to injuries or death.

The CARESCAPE R860 ventilator’s backup batteries, including replacement backup batteries, were recalled as they were running out earlier-than-expected, which could cause the device to shut down preventing the patient from receiving breathing support, the U.S. Food and Drug Administration said.

The CARESCAPE R860 ventilators use the main power via a wall plug to operate and the device’s backup battery is meant to keep it running in situations such as patient transport. read more


Target will cover employees’ travel to other states for abortions, company memo says

Target will cover employees’ travel if they live in a state where abortion is banned, according to a company memo obtained by CNBC.

The new policy will take effect in July, according to the email, which was sent to employees Monday from Target’s Chief Human Resources Officer Melissa Kremer.

“For years, our healthcare benefits have included some financial support for travel, when team members needed select healthcare procedures that weren’t available where they live,” Kremer said in the memo. “A few months ago, we started re-evaluating our benefits with the goal of understanding what it would look like if we broadened the travel reimbursement to any care that’s needed and covered – but not available in the team member’s community. This effort became even more relevant as we learned about the Supreme Court’s ruling on abortion, given that it would impact access to healthcare in some states.” read more